Skip to main content
All lobbying filings

JOHNSON & JOHNSON SERVICES, INC.

Lobbying for JOHNSON & JOHNSON SERVICES INC

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $1,510,000.00 expenses · posted Jan 20, 2026

Official filing document

 Bills named in this filing 26
  • HR 1539
    Medical Device Electronic Labeling Act
  • HR 929
    Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
  • S 266
    Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
  • HR 946
    ORPHAN Cures Act
  • S 864
    HELP Copays Act
  • HR 2214
    DRUG Act
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • S 832
    EPIC Act of 2025
  • S 1954
    Biosimilar Red Tape Elimination Act
  • HR 5526
    Biosimilar Red Tape Elimination Act
  • HR 2527
    Early Detection of Vision Impairments for Children Act of 2025
  • HR 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • HR 4282
    Contact Lens Prescription Verification Modernization Act
  • HR 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
  • S 1399
    Health Tech Investment Act
  • HR 6167
    HEALTH Act of 2025
  • HRES 1301
    Supporting the designation of May 29, 2026, as "Mental Health Awareness in Agriculture Day" to raise awareness around m…
  • S 1040
    Drug Competition Enhancement Act
  • S 1041
    Affordable Prescriptions for Patients Act
  • S 1097
    Interagency Patent Coordination and Improvement Act of 2025
  • HR 3269
    ETHIC Act
  • S 2276
    ETHIC Act
  • S 2658
    Medication Affordability and Patent Integrity Act
  • HR 1109
    Litigation Transparency Act of 2025
  • HR 2675
    Protecting Our Courts from Foreign Manipulation Act
 Lobbying activity 9
Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6167, the Health Tech Investment Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing

Budget/Appropriations

- Issues related to stroke care

Copyright/Patent/Trademark

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property - patent thickets - patent fees

Law Enforcement/Crime/Criminal Justice

Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - H.R.2675, Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding

Pharmacy

- Issues related to the SUPPORT Act

Science/Technology

Issues related to - artificial intelligence - data privacy - cybersecurity - robotics

Taxation/Internal Revenue Code

Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax

Veterans

Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program - military/veterans affairs health workforce and talent workforce

Trade (domestic/foreign)

- Issues related to USMCA review and renegotiation

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem